Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice
© 2021, Ito et al..
Heart failure is a major public health problem, and abnormal iron metabolism is common in patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a programmed necrosis. Iron release from ferritin storage is through nuclear receptor coactivator 4 (NCOA4)-mediated autophagic degradation, known as ferritinophagy. However, the role of ferritinophagy in the stressed heart remains unclear. Deletion of Ncoa4 in mouse hearts reduced left ventricular chamber size and improved cardiac function along with the attenuation of the upregulation of ferritinophagy-mediated ferritin degradation 4 weeks after pressure overload. Free ferrous iron overload and increased lipid peroxidation were suppressed in NCOA4-deficient hearts. A potent inhibitor of lipid peroxidation, ferrostatin-1, significantly mitigated the development of pressure overload-induced dilated cardiomyopathy in wild-type mice. Thus, the activation of ferritinophagy results in the development of heart failure, whereas inhibition of this process protects the heart against hemodynamic stress.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
eLife - 10(2021) vom: 02. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ito, Jumpei [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 02.02.2022 Date Revised 26.02.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.7554/eLife.62174 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320872009 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM320872009 | ||
003 | DE-627 | ||
005 | 20240229152640.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7554/eLife.62174 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM320872009 | ||
035 | |a (NLM)33526170 | ||
035 | |a (PII)e62174 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ito, Jumpei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.02.2022 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021, Ito et al. | ||
520 | |a Heart failure is a major public health problem, and abnormal iron metabolism is common in patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a programmed necrosis. Iron release from ferritin storage is through nuclear receptor coactivator 4 (NCOA4)-mediated autophagic degradation, known as ferritinophagy. However, the role of ferritinophagy in the stressed heart remains unclear. Deletion of Ncoa4 in mouse hearts reduced left ventricular chamber size and improved cardiac function along with the attenuation of the upregulation of ferritinophagy-mediated ferritin degradation 4 weeks after pressure overload. Free ferrous iron overload and increased lipid peroxidation were suppressed in NCOA4-deficient hearts. A potent inhibitor of lipid peroxidation, ferrostatin-1, significantly mitigated the development of pressure overload-induced dilated cardiomyopathy in wild-type mice. Thus, the activation of ferritinophagy results in the development of heart failure, whereas inhibition of this process protects the heart against hemodynamic stress | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a autophagy | |
650 | 4 | |a biochemistry | |
650 | 4 | |a chemical biology | |
650 | 4 | |a ferritin | |
650 | 4 | |a heart failure | |
650 | 4 | |a iron | |
650 | 4 | |a medicine | |
650 | 4 | |a mouse | |
650 | 4 | |a necrosis | |
650 | 7 | |a Cyclohexylamines |2 NLM | |
650 | 7 | |a NcoA4 protein, mouse |2 NLM | |
650 | 7 | |a Nuclear Receptor Coactivators |2 NLM | |
650 | 7 | |a Phenylenediamines |2 NLM | |
650 | 7 | |a ferrostatin-1 |2 NLM | |
650 | 7 | |a Ferritins |2 NLM | |
650 | 7 | |a 9007-73-2 |2 NLM | |
650 | 7 | |a Iron |2 NLM | |
650 | 7 | |a E1UOL152H7 |2 NLM | |
700 | 1 | |a Omiya, Shigemiki |e verfasserin |4 aut | |
700 | 1 | |a Rusu, Mara-Camelia |e verfasserin |4 aut | |
700 | 1 | |a Ueda, Hiromichi |e verfasserin |4 aut | |
700 | 1 | |a Murakawa, Tomokazu |e verfasserin |4 aut | |
700 | 1 | |a Tanada, Yohei |e verfasserin |4 aut | |
700 | 1 | |a Abe, Hajime |e verfasserin |4 aut | |
700 | 1 | |a Nakahara, Kazuki |e verfasserin |4 aut | |
700 | 1 | |a Asahi, Michio |e verfasserin |4 aut | |
700 | 1 | |a Taneike, Manabu |e verfasserin |4 aut | |
700 | 1 | |a Nishida, Kazuhiko |e verfasserin |4 aut | |
700 | 1 | |a Shah, Ajay M |e verfasserin |4 aut | |
700 | 1 | |a Otsu, Kinya |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 10(2021) vom: 02. Feb. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g day:02 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.62174 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |b 02 |c 02 |